Click for best price
Ulcerative Colitis Immunology Drugs Market Size, Share 2022
This report contains market size and forecasts of Ulcerative Colitis Immunology Drugs in global, including the following market information:
Global Ulcerative Colitis Immunology Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ulcerative Colitis Immunology Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Ulcerative Colitis Immunology Drugs companies in 2021 (%)
The global Ulcerative Colitis Immunology Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adalimumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ulcerative Colitis Immunology Drugs include Janssen Biotech, Inc., Bristol-Myers Squibb Company, AbbVie Inc., UCBCares, AMGEN, Celltrion Healthcare, Biogen, Genentech USA, Inc. and ROCHE and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ulcerative Colitis Immunology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Immunology Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, by Type, 2021 (%)
Adalimumab
Certolizumab Pegol
Tofacitinib
Etanercept
Golimumab
Abatacept
Infliximab
Others
Global Ulcerative Colitis Immunology Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Crohn's Disease(CD)
Ankylosing Spondylitis(AS)
Psoriasis(Ps)
Ulcerative Colitis(UC)
Global Ulcerative Colitis Immunology Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ulcerative Colitis Immunology Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ulcerative Colitis Immunology Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ulcerative Colitis Immunology Drugs revenues share in global market, 2021 (%)
Key companies Ulcerative Colitis Immunology Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Ulcerative Colitis Immunology Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Biotech, Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UCBCares
AMGEN
Celltrion Healthcare
Biogen
Genentech USA, Inc.
ROCHE
Pfizer Inc.
| Report Attributes |
Report Details |
| Report Title |
Ulcerative Colitis Immunology Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ulcerative Colitis Immunology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ulcerative Colitis Immunology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Immunology Drugs Overall Market Size
2.1 Global Ulcerative Colitis Immunology Drugs Market Size: 2021 VS 2028
2.2 Global Ulcerative Colitis Immunology Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Ulcerative Colitis Immunology Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Ulcerative Colitis Immunology Drugs Players in Global Market
3.2 Top Global Ulcerative Colitis Immunology Drugs Companies Ranked by Revenue
3.3 Global Ulcerative Colitis Immunology Drugs Revenue by Companies
3.4 Global Ulcerative Colitis Immunology Drugs Sales by Companies
3.5 Global Ulcerative Colitis Immunology Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Ulcerative Colitis Immunology Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Ulcerative Colitis Immunology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ulcerative Colitis Immunology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ulcerative Colitis Immunology Drugs Market Size Markets, 2021 & 2028
4.1.2 Adalimumab
4.1.3 Certolizumab Pegol
4.1.4 Tofacitinib
4.1.5 Etanercept
4.1.6 Golimumab
4.1.7 Abatacept
4.1.8 Infliximab
4.1.9 Others
4.2 By Type - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
4.2.1 By Type - Global Ulcerative Colitis Immunology Drugs Revenue, 2017-2022
4.2.2 By Type - Global Ulcerative Colitis Immunology Drugs Revenue, 2023-2028
4.2.3 By Type - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
4.3.1 By Type - Global Ulcerative Colitis Immunology Drugs Sales, 2017-2022
4.3.2 By Type - Global Ulcerative Colitis Immunology Drugs Sales, 2023-2028
4.3.3 By Type - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Ulcerative Colitis Immunology Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Ulcerative Colitis Immunology Drugs Market Size, 2021 & 2028
5.1.2 Rheumatoid Arthritis
5.1.3 Crohn's Disease(CD)
5.1.4 Ankylosing Spondylitis(AS)
5.1.5 Psoriasis(Ps)
5.1.6 Ulcerative Colitis(UC)
5.2 By Application - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
5.2.1 By Application - Global Ulcerative Colitis Immunology Drugs Revenue, 2017-2022
5.2.2 By Application - Global Ulcerative Colitis Immunology Drugs Revenue, 2023-2028
5.2.3 By Application - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
5.3.1 By Application - Global Ulcerative Colitis Immunology Drugs Sales, 2017-2022
5.3.2 By Application - Global Ulcerative Colitis Immunology Drugs Sales, 2023-2028
5.3.3 By Application - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Ulcerative Colitis Immunology Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Ulcerative Colitis Immunology Drugs Market Size, 2021 & 2028
6.2 By Region - Global Ulcerative Colitis Immunology Drugs Revenue & Forecasts
6.2.1 By Region - Global Ulcerative Colitis Immunology Drugs Revenue, 2017-2022
6.2.2 By Region - Global Ulcerative Colitis Immunology Drugs Revenue, 2023-2028
6.2.3 By Region - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Ulcerative Colitis Immunology Drugs Sales & Forecasts
6.3.1 By Region - Global Ulcerative Colitis Immunology Drugs Sales, 2017-2022
6.3.2 By Region - Global Ulcerative Colitis Immunology Drugs Sales, 2023-2028
6.3.3 By Region - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Ulcerative Colitis Immunology Drugs Revenue, 2017-2028
6.4.2 By Country - North America Ulcerative Colitis Immunology Drugs Sales, 2017-2028
6.4.3 US Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.4.4 Canada Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.4.5 Mexico Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Ulcerative Colitis Immunology Drugs Sales, 2017-2028
6.5.3 Germany Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.4 France Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.5 U.K. Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.6 Italy Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.7 Russia Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.5.9 Benelux Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Ulcerative Colitis Immunology Drugs Sales, 2017-2028
6.6.3 China Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.6.4 Japan Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.6.5 South Korea Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.6.7 India Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Ulcerative Colitis Immunology Drugs Revenue, 2017-2028
6.7.2 By Country - South America Ulcerative Colitis Immunology Drugs Sales, 2017-2028
6.7.3 Brazil Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.7.4 Argentina Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, 2017-2028
6.8.3 Turkey Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.8.4 Israel Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
6.8.6 UAE Ulcerative Colitis Immunology Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Janssen Biotech, Inc.
7.1.1 Janssen Biotech, Inc. Corporate Summary
7.1.2 Janssen Biotech, Inc. Business Overview
7.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.1.4 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Janssen Biotech, Inc. Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 AbbVie Inc.
7.3.1 AbbVie Inc. Corporate Summary
7.3.2 AbbVie Inc. Business Overview
7.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.3.4 AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.3.5 AbbVie Inc. Key News
7.4 UCBCares
7.4.1 UCBCares Corporate Summary
7.4.2 UCBCares Business Overview
7.4.3 UCBCares Ulcerative Colitis Immunology Drugs Major Product Offerings
7.4.4 UCBCares Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.4.5 UCBCares Key News
7.5 AMGEN
7.5.1 AMGEN Corporate Summary
7.5.2 AMGEN Business Overview
7.5.3 AMGEN Ulcerative Colitis Immunology Drugs Major Product Offerings
7.5.4 AMGEN Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.5.5 AMGEN Key News
7.6 Celltrion Healthcare
7.6.1 Celltrion Healthcare Corporate Summary
7.6.2 Celltrion Healthcare Business Overview
7.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Major Product Offerings
7.6.4 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Celltrion Healthcare Key News
7.7 Biogen
7.7.1 Biogen Corporate Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Ulcerative Colitis Immunology Drugs Major Product Offerings
7.7.4 Biogen Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Biogen Key News
7.8 Genentech USA, Inc.
7.8.1 Genentech USA, Inc. Corporate Summary
7.8.2 Genentech USA, Inc. Business Overview
7.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.8.4 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Genentech USA, Inc. Key News
7.9 ROCHE
7.9.1 ROCHE Corporate Summary
7.9.2 ROCHE Business Overview
7.9.3 ROCHE Ulcerative Colitis Immunology Drugs Major Product Offerings
7.9.4 ROCHE Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.9.5 ROCHE Key News
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Corporate Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Major Product Offerings
7.10.4 Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Inc. Key News
8 Global Ulcerative Colitis Immunology Drugs Production Capacity, Analysis
8.1 Global Ulcerative Colitis Immunology Drugs Production Capacity, 2017-2028
8.2 Ulcerative Colitis Immunology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ulcerative Colitis Immunology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ulcerative Colitis Immunology Drugs Supply Chain Analysis
10.1 Ulcerative Colitis Immunology Drugs Industry Value Chain
10.2 Ulcerative Colitis Immunology Drugs Upstream Market
10.3 Ulcerative Colitis Immunology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ulcerative Colitis Immunology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ulcerative Colitis Immunology Drugs in Global Market
Table 2. Top Ulcerative Colitis Immunology Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Ulcerative Colitis Immunology Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Ulcerative Colitis Immunology Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Ulcerative Colitis Immunology Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Ulcerative Colitis Immunology Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Ulcerative Colitis Immunology Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Ulcerative Colitis Immunology Drugs Product Type
Table 9. List of Global Tier 1 Ulcerative Colitis Immunology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Immunology Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Ulcerative Colitis Immunology Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global Ulcerative Colitis Immunology Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales, (K Pcs), 2023-2028
Table 46. Janssen Biotech, Inc. Corporate Summary
Table 47. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 48. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Offerings
Table 51. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. AbbVie Inc. Corporate Summary
Table 53. AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 54. AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. UCBCares Corporate Summary
Table 56. UCBCares Ulcerative Colitis Immunology Drugs Product Offerings
Table 57. UCBCares Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. AMGEN Corporate Summary
Table 59. AMGEN Ulcerative Colitis Immunology Drugs Product Offerings
Table 60. AMGEN Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Celltrion Healthcare Corporate Summary
Table 62. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Offerings
Table 63. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Biogen Corporate Summary
Table 65. Biogen Ulcerative Colitis Immunology Drugs Product Offerings
Table 66. Biogen Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Genentech USA, Inc. Corporate Summary
Table 68. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 69. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. ROCHE Corporate Summary
Table 71. ROCHE Ulcerative Colitis Immunology Drugs Product Offerings
Table 72. ROCHE Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Pfizer Inc. Corporate Summary
Table 74. Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Offerings
Table 75. Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Ulcerative Colitis Immunology Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global Ulcerative Colitis Immunology Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Ulcerative Colitis Immunology Drugs Production by Region, 2017-2022 (K Pcs)
Table 79. Global Ulcerative Colitis Immunology Drugs Production by Region, 2023-2028 (K Pcs)
Table 80. Ulcerative Colitis Immunology Drugs Market Opportunities & Trends in Global Market
Table 81. Ulcerative Colitis Immunology Drugs Market Drivers in Global Market
Table 82. Ulcerative Colitis Immunology Drugs Market Restraints in Global Market
Table 83. Ulcerative Colitis Immunology Drugs Raw Materials
Table 84. Ulcerative Colitis Immunology Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Ulcerative Colitis Immunology Drugs Downstream
Table 86. Ulcerative Colitis Immunology Drugs Downstream Clients in Global Market
Table 87. Ulcerative Colitis Immunology Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ulcerative Colitis Immunology Drugs Segment by Type
Figure 2. Ulcerative Colitis Immunology Drugs Segment by Application
Figure 3. Global Ulcerative Colitis Immunology Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ulcerative Colitis Immunology Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ulcerative Colitis Immunology Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Ulcerative Colitis Immunology Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Ulcerative Colitis Immunology Drugs Revenue in 2021
Figure 9. By Type - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 19. US Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 24. Germany Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 33. China Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Ulcerative Colitis Immunology Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Ulcerative Colitis Immunology Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Ulcerative Colitis Immunology Drugs by Region, 2021 VS 2028
Figure 50. Ulcerative Colitis Immunology Drugs Industry Value Chain
Figure 51. Marketing Channels
